Most patients who receive a liver transplant take either ciclosporin or tacrolimus to prevent rejection. Shenoy et al. analyzed the pharmacoeconomics of ciclosporin versus tacrolimus ...

Ciclosporin is used as an immunosuppressive agent in the treatment of IBD, but can cause severe adverse effects, including kidney and nerve damage. In addition, patients with IBD are at risk of ...

Discover the effectiveness of three immunomodulatory therapies combined with corticosteroids in preventing uveitis relapse in ...

Introduction The efficacy of intravenous Ciclosporin in the treatment of acute severe steroid refractory ulcerative colitis is variable in several small studies. 1 2 The benefit of immunosuppression ...

Aims Ciclosporin is one of most used immunosuppressants in the Haematopoietic Stem Cell Transplant (HSCT) setting. It is used for, amongst other reasons, Graft versus Host Disease prophylaxis, and ...

Truelove and Witts published the first placebo-controlled, randomised clinical trial in inflammatory bowel disease (IBD), which showed the superiority of cortisone for the treatment of acute ...

Treatment with ciclosporin freed the patient from repeated IVIg administration. Therapeutic responses in 14 subsequent cases including three patients who showed improvement with ciclosporin are also ...

It is not addictive. Do not take Cyclosporin Sandoz if you have ever had an allergic reaction to ciclosporin, the active ingredient in Cyclosporin Sandoz, or to any of the other ingredients listed ...

To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...

Of the 62 (2.0%) patients treated with immunosuppressive agents, 16 (25.8%) received 6-MP, 39 (63.0%) received azathioprine and five (8.1%) received ciclosporin A. Of all the patients, 378 (12.5% ...

The aim of this study was to assess long-term outcome of patients included in a randomised trial comparing ciclosporin and infliximab. Design Between 2007 and 2010, 115 patients with ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved ...